Cargando…
Hypoxia-induced ALDH3A1 promotes the proliferation of non-small-cell lung cancer by regulating energy metabolism reprogramming
Aldehyde dehydrogenase 3A1 (ALDH3A1) is an NAD(+)-dependent enzyme that is closely related to tumor development. However, its role in non-small-cell lung cancer (NSCLC) has not been elucidated. This study aimed to clarify the mechanism of ALDH3A1 and identify potential therapeutic targets for NSCLC....
Autores principales: | Chen, Yang, Yan, Hongfei, Yan, Lirong, Wang, Ximing, Che, Xiaofang, Hou, Kezuo, Yang, Yi, Li, Xuena, Li, Yaming, Zhang, Ye, Hu, Xuejun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511739/ https://www.ncbi.nlm.nih.gov/pubmed/37730658 http://dx.doi.org/10.1038/s41419-023-06142-y |
Ejemplares similares
-
Assessment of Nine Driver Gene Mutations in Surgically Resected Samples from Patients with Non-Small-Cell Lung Cancer
por: Wang, Shuo, et al.
Publicado: (2020) -
Knockdown of G‐protein‐signaling modulator 2 promotes metastasis of non‐small‐cell lung cancer by inducing the expression of Snail
por: Deng, Mingming, et al.
Publicado: (2020) -
Integrin α5 promotes migration and invasion through the FAK/STAT3/AKT signaling pathway in icotinib-resistant non-small cell lung cancer cells
por: Yang, Yang, et al.
Publicado: (2021) -
NPTX1 promotes metastasis via integrin/FAK signaling in gastric cancer
por: Yan, Hongfei, et al.
Publicado: (2019) -
Bioinformatics-Based Identification of HDAC Inhibitors as Potential Drugs to Target EGFR Wild-Type Non-Small-Cell Lung Cancer
por: Wang, Yizhe, et al.
Publicado: (2021)